Literature DB >> 3160651

The I-J glycoprotein: genetic control, biochemistry, and function.

C E Hayes, K K Klyczek.   

Abstract

The I-J molecule is a mannosylated protein expressed early in T cell ontogeny in partially shielded form, later fully exposed on an activated T cell subset. Others determined a 25-30,000 molecular weight for cellular (Kumagai et al. 1984) and secreted forms (Taniguchi et al. 1984). Both the cell membrane and secreted types seem to govern genetically-restricted interactions completing suppressor cell circuits. The soluble I-J polypeptide has no antigen-binding site, but associates with an antigen-binding chain via disulfide bonding (Taniguchi et al. 1984, Lei et al. 1983). Similarly, evidence suggests that cellular I-J molecules are part of or proximal to T cell antigen receptor complexes (Fig. 4). At least two genes control T cell I-Jk expression, one apparently in I-E, another on chromosome 4. Undiscovered loci may also participate. Since I-J+ T cells do not transcribe I-region DNA, the I-E gene must be an untranscribed regulatory element in T cells or a protein translated in the host environment. If in the host environment, it probably does not function enzymatically to form T cell I-J epitopes; removed from the host, T cells biosynthesize complete I-J determinants. Host I-E gene products may regulate I-J expression in an early T cell maturation step. For example, the E alpha E beta proteins of thymic macrophages and epithelial cells may drive the expansion of T cells with E alpha E beta-complementary receptors encoded by I-J genes outside H-2. Genetic control of this self receptor would then apparently map to the selective ligand gene, I-E, as well as the I-J structural gene elsewhere (Klyczek et al. 1984b). This attractive theory, proposed in its original form by Jerne (1971) and later by Schrader (1979), has received significant support. Definitive proof must await further experimentation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3160651     DOI: 10.1111/j.1600-065x.1985.tb00469.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  6 in total

Review 1.  Identification and characterization of CD8+ suppressor T cells.

Authors:  James C Zimring; Judith A Kapp
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

2.  The I-J-disparate mouse strains B10.A(3R) and B10.A(5R) have identical E beta sequences.

Authors:  J Gorski; C E Hayes
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

3.  Visualization of anti-I-J antibody binding sites on bone marrow-derived macrophages.

Authors:  R M Nakamura; K Kitamura
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

4.  Suppressor T cells, antigen-presenting cells and the role of I-J restriction in oral tolerance to ovalbumin.

Authors:  A M Mowat; A G Lamont; D M Parrott
Journal:  Immunology       Date:  1988-05       Impact factor: 7.397

5.  Accessory cell presentation of hapten-modified self.

Authors:  J P Cogswell; D W Scott
Journal:  Surv Immunol Res       Date:  1985

6.  Altered I-J phenotype in E alpha transgenic mice.

Authors:  P M Flood; C Benoist; D Mathis; D B Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.